Holding pharma stocks? Minor correction offers buying opportunity, says analyst
Bathini’s comments come at a time when investors are reassessing sector leadership in a volatile market, with pharma stocks reacting to a mix of regulatory, product and business-specific developments.
Bathini’s comments come at a time when investors are reassessing sector leadership in a volatile market, with pharma stocks reacting to a mix of regulatory, product and business-specific developments.
What's Your Reaction?
